Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brandon J Lujan

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Ophthalmology. Retina|February 5, 2022
Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical TrialClement K Chan, Maziar Lalezary, Prema Abraham, et al.
Ophthalmology. Retina|April 10, 2025
Phenotypic Spectrum of Benign Lobular Inner Nuclear Layer Proliferations: A Multicenter Analysis and Review of the LiteratureMichael Javaheri, Christian J Sanfilippo, Sundeep K Kasi, et al.
Ophthalmology Science|September 10, 2024
Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility StudyZufar Mulyukov, Pearse A Keane, Jayashree Sahni, et al.
Retina (Philadelphia, Pa.)|July 14, 2015
EXPANDED CLINICAL SPECTRUM OF MULTIPLE EVANESCENT WHITE DOT SYNDROME WITH MULTIMODAL IMAGINGMarcela Marsiglia, Roberto Gallego-Pinazo, Eduardo Cunha de Souza, et al.
The British Journal of Ophthalmology|May 24, 2014
The reliability of parafoveal cone density measurementsBenjamin S Liu, Sergey Tarima, Alexis Visotcky, et al.
American Journal of Ophthalmology|March 6, 2022
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5Maria A Parker, Laura R Erker, Isabelle Audo, et al.
Nature Medicine|February 26, 2020
Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGRJasmina Cehajic-Kapetanovic, Kanmin Xue, Cristina Martinez-Fernandez de la Camara, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Ophthalmology. Retina|February 5, 2022
Prophylactic Ranibizumab to Prevent Neovascular Age-Related Macular Degeneration in Vulnerable Fellow Eyes: A Randomized Clinical TrialClement K Chan, Maziar Lalezary, Prema Abraham, et al.
Ophthalmology. Retina|April 10, 2025
Phenotypic Spectrum of Benign Lobular Inner Nuclear Layer Proliferations: A Multicenter Analysis and Review of the LiteratureMichael Javaheri, Christian J Sanfilippo, Sundeep K Kasi, et al.
Ophthalmology Science|September 10, 2024
Artificial Intelligence-Based Disease Activity Monitoring to Personalized Neovascular Age-Related Macular Degeneration Treatment: A Feasibility StudyZufar Mulyukov, Pearse A Keane, Jayashree Sahni, et al.
Retina (Philadelphia, Pa.)|July 14, 2015
EXPANDED CLINICAL SPECTRUM OF MULTIPLE EVANESCENT WHITE DOT SYNDROME WITH MULTIMODAL IMAGINGMarcela Marsiglia, Roberto Gallego-Pinazo, Eduardo Cunha de Souza, et al.
The British Journal of Ophthalmology|May 24, 2014
The reliability of parafoveal cone density measurementsBenjamin S Liu, Sergey Tarima, Alexis Visotcky, et al.
American Journal of Ophthalmology|March 6, 2022
Three-Year Safety Results of SAR422459 (EIAV-ABCA4) Gene Therapy in Patients With ABCA4-Associated Stargardt Disease: An Open-Label Dose-Escalation Phase I/IIa Clinical Trial, Cohorts 1-5Maria A Parker, Laura R Erker, Isabelle Audo, et al.
Nature Medicine|February 26, 2020
Initial results from a first-in-human gene therapy trial on X-linked retinitis pigmentosa caused by mutations in RPGRJasmina Cehajic-Kapetanovic, Kanmin Xue, Cristina Martinez-Fernandez de la Camara, et al.
Pageof 7